0.485
price down icon43.98%   -0.3807
pre-market  시장 영업 전:  .49   0.005   +1.03%
loading
전일 마감가:
$0.8657
열려 있는:
$0.568
하루 거래량:
15.85M
Relative Volume:
26.96
시가총액:
$18.54M
수익:
$356.60K
순이익/손실:
$-24.32M
주가수익비율:
-0.0525
EPS:
-9.24
순현금흐름:
$-27.24M
1주 성능:
-46.23%
1개월 성능:
-52.45%
6개월 성능:
-80.36%
1년 성능:
-85.21%
1일 변동 폭
Value
$0.43
$0.5811
1주일 범위
Value
$0.43
$0.98
52주 변동 폭
Value
$0.43
$11.18

Geovax Labs Inc Stock (GOVX) Company Profile

Name
명칭
Geovax Labs Inc
Name
전화
678-384-7220
Name
주소
1900 LAKE PARK DRIVE, SMYRNA
Name
직원
17
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
GOVX's Discussions on Twitter

GOVX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GOVX
Geovax Labs Inc
0.485 18.54M 356.60K -24.32M -27.24M -9.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-15 재확인 Alliance Global Partners Buy
2025-04-15 재확인 D. Boral Capital Buy
2024-11-11 개시 Alliance Global Partners Buy
2024-07-16 개시 ROTH MKM Buy
2020-11-19 개시 Maxim Group Buy

Geovax Labs Inc 주식(GOVX)의 최신 뉴스

pulisher
Jun 18, 2025

Financial Health Check: Examining Geovax Labs Inc (GOVX)’s Key Ratios - DWinneX

Jun 18, 2025
pulisher
Jun 17, 2025

Geovax Labs Inc Inc. (GOVX) Price Performance: Is It Undervalued or Overvalued? - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

GeoVax Labs (GOVX) Gains Positive EMA Feedback, Potential Speedier Approval | GOVX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

GeoVax Highlights Positive Immune Response Results From GEO-CM04S1 in CLL Patients at the European Hematology Association 2025 Meeting - Yahoo Finance

Jun 17, 2025
pulisher
Jun 17, 2025

GeoVax Advances Toward European Approval for Mpox and Smallpox Vaccine with EMA's Support - citybuzz -

Jun 17, 2025
pulisher
Jun 17, 2025

GeoVax Labs’ (GOVX) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

GeoVax Labs (GOVX) Issues New Stock Units with Warrants | GOVX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

GeoVax Labs (GOVX) Gains EMA Approval for Phase 3 Vaccine Trial | GOVX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

GOVX: Geovax Labs Receives Buy Rating from Analyst | GOVX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

GeoVax Receives Favorable European Regulatory Guidance Supporting Streamlined Development Pathway for GEO-MVA - Yahoo Finance

Jun 16, 2025
pulisher
Jun 12, 2025

GeoVax to Showcase Innovative Vaccines and Therapies at BIO International Convention 2025 - citybuzz -

Jun 12, 2025
pulisher
Jun 12, 2025

GeoVax to Participate in BIO International Convention 2025 - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Geovax highlights progress on mpox vaccine and COVID-19 trial advancements - MSN

Jun 12, 2025
pulisher
Jun 11, 2025

GeoVax Advances GEO-MVA Vaccine Development Amid WHO's Mpox Emergency Declaration - citybuzz -

Jun 11, 2025
pulisher
Jun 11, 2025

GeoVax Responds to WHO's Fourth Declaration of Mpox as a Global Public Health Emergency - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Robinhood Markets, Inc. Reports May 2025 Operating Data - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

GeoVax to Showcase Positive Immune Response Data for GEO-CM04S1 in CLL Patients at EHA 2025 Congress - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

42,275 Shares in GeoVax Labs, Inc. (NASDAQ:GOVX) Acquired by Citadel Advisors LLC - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

GeoVax’s Multi-Antigen COVID-19 Vaccine Candidates Show Promise Against Variants - citybuzz -

Jun 09, 2025
pulisher
Jun 09, 2025

GeoVax Highlights Broad Cross-Protective Immunity of Multi-Antigen COVID-19 Vaccine Candidates at Keystone Symposia - Yahoo Finance

Jun 09, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Invests $29,000 in GeoVax Labs, Inc. (NASDAQ:GOVX) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

GeoVax to Showcase Innovative COVID 19 Vaccine Data at the Keystone Symposia on Vaccinology - Yahoo Finance

Jun 04, 2025
pulisher
May 30, 2025

GeoVax Labs, Inc. (NASDAQ:GOVX) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 30, 2025
pulisher
May 29, 2025

GeoVax Congratulates Bipartisan Senate Action to Onshore Critical Medical Manufacturing - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

GeoVax Labs (NASDAQ:GOVX) Shares Up 6.9% – Should You Buy? - Defense World

May 28, 2025
pulisher
May 27, 2025

GeoVax Commends FDA's Shift to Risk-Based COVID-19 Vaccination Guidance - Yahoo Finance

May 27, 2025
pulisher
May 21, 2025

GeoVax Applauds EQUIP-A-Pharma Initiative, Reinforces Commitment to Domestic Vaccine Manufacturing and Biodefense Innovation - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

GeoVax Reaffirms Urgent Need for Multi-Antigen COVID-19 Vaccines as CDC Shifts Recommendations - Yahoo Finance

May 20, 2025
pulisher
May 11, 2025

GeoVax Labs (GOVX) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

GeoVax Highlights Dual Protective Potential of GEO-CM04S1 Following Presentation at the AAI Annual Meeting 2025 - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

GeoVax Strengthens Patent Portfolio for Innovative Cancer Therapy Approach - citybuzz -

May 08, 2025
pulisher
May 07, 2025

GeoVax Expands Gedeptin(R) Patent Portfolio - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

GeoVax Applauds White House Executive Order Supporting U.S. Pharmaceutical Manufacturing; Highlights Progress in Domestic MVA Vaccine Production - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

MarketsMedicine Hat News - FinancialContent

May 06, 2025
pulisher
May 05, 2025

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia - ADVFN

May 05, 2025
pulisher
May 05, 2025

D. Boral Capital Cuts GeoVax Labs (NASDAQ:GOVX) Price Target to $9.00 - Defense World

May 05, 2025
pulisher
May 05, 2025

GeoVax Labs, Inc. (NASDAQ:GOVX) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 05, 2025
pulisher
May 04, 2025

Form 8-KCurrent report - ADVFN

May 04, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Has $223,000 Holdings in GeoVax Labs, Inc. (NASDAQ:GOVX) - Defense World

May 04, 2025
pulisher
May 03, 2025

Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and Baxter International (BAX) - The Globe and Mail

May 03, 2025
pulisher
May 02, 2025

GeoVax Labs Earnings Call: Mixed Sentiment and Future Prospects - TipRanks

May 02, 2025
pulisher
May 02, 2025

Geovax Labs (GOVX) Faces Price Target Reduction by Analyst | GOV - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Geovax Labs (GOVX) Faces Price Target Reduction by Analyst | GOVX Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

May 02, 2025
pulisher
May 02, 2025

GeoVax Labs Reports Q1 2025 Progress Amid Challenges - TipRanks

May 02, 2025
pulisher
May 01, 2025

Earnings call transcript: GeoVax Q1 2025 reveals revenue from BARDA contract - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

GeoVax Labs Q1 2025 Earnings Call Transcript - MarketBeat

May 01, 2025
pulisher
May 01, 2025

GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

May 01, 2025
pulisher
Apr 29, 2025

GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting - Yahoo Finance

Apr 29, 2025
pulisher
Apr 28, 2025

Geovax Labs is a buy, Roth says - Cantech Letter

Apr 28, 2025

Geovax Labs Inc (GOVX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Geovax Labs Inc 주식 (GOVX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Sharkey John W.
VP, Business Development
Apr 10 '25
Buy
0.99
6,000
5,940
6,191
DODD DAVID A
President, CEO
Apr 01 '25
Buy
1.08
10,000
10,800
36,661
Reynolds Mark
CFO
Mar 31 '25
Buy
1.08
6,800
7,343
14,013
DODD DAVID A
President, CEO
Aug 09 '24
Buy
1.95
8,000
15,600
26,661
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):